Your browser doesn't support javascript.
loading
Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia.
Xie, Zhifu; Zhang, Mei; Song, Qian; Cheng, Long; Zhang, Xinwen; Song, Gaolei; Sun, Xinyu; Gu, Min; Zhou, Chendong; Zhang, Yangming; Zhu, Kexin; Yin, Jianpeng; Chen, Xiaoyan; Li, Jingya; Nan, Fajun.
Afiliación
  • Xie Z; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Zhang M; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Song Q; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Cheng L; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Zhang X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Song G; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Sun X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Gu M; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Zhou C; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Zhang Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Zhu K; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Yin J; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Chen X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Li J; Burgeon Therapeutics Co., Ltd., Shanghai 201203, China.
  • Nan F; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Acta Pharm Sin B ; 13(2): 739-753, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36873173
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Acta Pharm Sin B Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Acta Pharm Sin B Año: 2023 Tipo del documento: Article País de afiliación: China